世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2015年
48期
41-41,53
,共2页
老年%原发性高血压%缬沙坦%美托洛尔%临床疗效
老年%原髮性高血壓%纈沙坦%美託洛爾%臨床療效
노년%원발성고혈압%힐사탄%미탁락이%림상료효
old age%essential hypertension%Stan%Mei TORO M%clinical curative effect
目的:观察和分析对老年原发性高血压患者采用缬沙坦配伍美托洛尔进行治疗的临床疗效。方法:选取2013年5月~2015年5月间我院收治的老年原发性高血压患者80例作为临床研究对象,使用随机数字列表法将其随机分为研究组(n=40例)和对照组(n=40例)。对照组患者采用硝苯地平联合美托洛尔进行治疗,研究组患者采用缬沙坦配伍美托洛尔进行治疗。观察和对比两组患者的临床治疗效果。结果:经治疗后,研究组患者治疗的总有效率(95.0%)明显高于对照组(82.5%),(P<0.05)差异均有统计学意义。结论:对老年原发性高血压患者采用缬沙坦配伍美托洛尔进行治疗具有良好的临床疗效,值得在临床上进一步推广。
目的:觀察和分析對老年原髮性高血壓患者採用纈沙坦配伍美託洛爾進行治療的臨床療效。方法:選取2013年5月~2015年5月間我院收治的老年原髮性高血壓患者80例作為臨床研究對象,使用隨機數字列錶法將其隨機分為研究組(n=40例)和對照組(n=40例)。對照組患者採用硝苯地平聯閤美託洛爾進行治療,研究組患者採用纈沙坦配伍美託洛爾進行治療。觀察和對比兩組患者的臨床治療效果。結果:經治療後,研究組患者治療的總有效率(95.0%)明顯高于對照組(82.5%),(P<0.05)差異均有統計學意義。結論:對老年原髮性高血壓患者採用纈沙坦配伍美託洛爾進行治療具有良好的臨床療效,值得在臨床上進一步推廣。
목적:관찰화분석대노년원발성고혈압환자채용힐사탄배오미탁락이진행치료적림상료효。방법:선취2013년5월~2015년5월간아원수치적노년원발성고혈압환자80례작위림상연구대상,사용수궤수자렬표법장기수궤분위연구조(n=40례)화대조조(n=40례)。대조조환자채용초분지평연합미탁락이진행치료,연구조환자채용힐사탄배오미탁락이진행치료。관찰화대비량조환자적림상치료효과。결과:경치료후,연구조환자치료적총유효솔(95.0%)명현고우대조조(82.5%),(P<0.05)차이균유통계학의의。결론:대노년원발성고혈압환자채용힐사탄배오미탁락이진행치료구유량호적림상료효,치득재림상상진일보추엄。
Objective: To observe and analysis of senile primary hypertension by valsartan combined with metoprolol for treatment.Methods: a total of 2013 may 2015 may treated in our hospital between senile primary hypertension patients 80 cases as a clinical study, using the method of random number list the were randomly divided into study group (n = 40) and control group (n = 40). The control group of patients with nifedipine combined with metoprolol in the treatment, the patients in the study group by valsartan combined with metoprolol treatment. Observation and comparison of the clinical therapeutic effect of the two groups of patients.Results:after treatment, the total effective rate of the study group (95%) was signiifcantly higher than that of the control group (82.5%), the difference was statistically signiifcant (P < 0.05).Conclusion: in elderly patients with primary hypertension by valsartan combined with metoprolol treatment has good clinical efifcacy, is worthy of further promotion in clinical.